STOCK TITAN

Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 Form 4 Filings

AEFC NYSE

Every Form 4 that Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AEFC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AEFC filings page.

Rhea-AI Summary

AEGON LTD. director John F. McGarry acquired 61 Common Shares on September 24, 2026, as an award of dividend equivalent shares associated with his outstanding equity awards. His reported direct holdings after the award were 15,766 shares.

Rhea-AI Summary

AEGON Ltd. director Jay Stuart Ralph acquired 61 common shares on September 24, 2026, as a dividend equivalent award associated with outstanding equity awards. The reported price was $0.00 per share. Direct common-share holdings following the transaction were 9,027.

Rhea-AI Summary

AEGON LTD. director Leni Boeren acquired 51 common shares on September 24, 2026, as dividend equivalent shares associated with outstanding equity awards. Direct holdings after the award were 4,232 common shares.

Rhea-AI Summary

Aegon Ltd. director Thomas Peter Wellauer received an award of 61 dividend equivalent common shares on September 24, 2026, associated with his outstanding equity awards. His reported direct common-share holdings following the award were 11,308. The transaction reports a per-share price of $0.0000.

Rhea-AI Summary

Aegon Ltd. director Albert Benchimol acquired 61 common shares on September 24, 2026, as an award of dividend equivalent shares associated with his outstanding equity awards. His reported direct holdings following the transaction were 15,766 common shares. The transaction was an award acquisition, not a market purchase or sale.

Rhea-AI Summary

AEGON Ltd. director David L. Herzog acquired 257 Common Shares on September 24, 2026, through an award of dividend equivalent shares associated with his outstanding equity awards. The reported transaction price was $0.0000 per share, and his reported direct holdings following the transaction were 24,985 Common Shares.

Rhea-AI Summary

AEGON LTD. director Caroline Frances Ramsay acquired 61 Common Shares on September 24, 2026, as dividend equivalent shares associated with her outstanding equity awards. Her direct holdings following the transaction were 10,770 Common Shares.

Rhea-AI Summary

AEGON LTD. director Lori Dickerson Fouche acquired 61 Common Shares on September 24, 2026, as an award of dividend equivalent shares associated with her outstanding equity awards. Her direct holdings following the award were 9,027 Common Shares. This was an award acquisition, not a market purchase.

Rhea-AI Summary

AEGON LTD. (AEG) reported that director Mark Alan Ellman acquired 61 common shares on September 24, 2026, as an award of dividend equivalent shares associated with his outstanding equity awards. His reported direct holdings after the award were 15,766 common shares. The reported transaction price was $0.00 per share.

Rhea-AI Summary

AEGON LTD. director Mark Alan Ellman reported acquiring 32 Common Shares as a compensation-related award. The shares were granted as dividend equivalent shares tied to his outstanding equity awards, rather than through an open-market purchase. Following this award, he directly holds 15,705 Common Shares.

Rhea-AI Summary

Boeren Leni reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Leni Boeren received an award of 21 Common Shares on July 6, 2026 as dividend equivalent shares tied to her outstanding equity awards. The shares were granted at $0.00 per share, bringing her direct holdings to 4,181 Common Shares.

Rhea-AI Summary

Wellauer Thomas Peter reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Thomas Peter Wellauer received an award of 32 Common Shares on July 6, 2026 at a stated price of $0.00 per share. The award represents dividend equivalent shares tied to his existing equity awards. Following this grant, he directly holds 11,247 Common Shares.

Rhea-AI Summary

McGarry John F reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director John F. McGarry reported receiving 32 Common Shares on 2026-07-06. The filing describes this as an award of dividend equivalent shares tied to his existing equity awards, with no cash price per share. After this compensation-related grant, he directly holds 15,705 Common Shares.

Rhea-AI Summary

Herzog David L reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director David L. Herzog received an award of 136 Common Shares on 2026-07-06 at no cost. The award represents dividend equivalent shares tied to his existing equity awards. Following this grant, he directly holds 24,728 Common Shares of AEGON LTD.

Rhea-AI Summary

AEGON LTD. director Ralph Jay Stuart reported a compensation-related share award. He acquired 32 Common Shares on 2026-07-06 at a stated price of $0.0000 per share, increasing his direct holdings to 8,966 shares. The footnote explains this represents dividend equivalent shares tied to his existing equity awards, rather than an open-market purchase.

Rhea-AI Summary

Fouche Lori Dickerson reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Lori Dickerson Fouché reported receiving an award of 32 common shares on July 6, 2026. These shares were granted as dividend equivalent shares tied to her outstanding equity awards, rather than purchased on the open market.

After this compensation-related grant, she directly holds a total of 8,966 common shares. The transaction reflects routine equity-based compensation and does not represent a discretionary market trade.

Rhea-AI Summary

BENCHIMOL ALBERT reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Albert Benchimol received an award of 32 Common Shares on 2026-07-06 at a price of $0.00 per share. This was a grant of dividend equivalent shares tied to his outstanding equity awards and is compensation-related rather than an open-market trade. Following this award, he directly holds 15,705 Common Shares.

Rhea-AI Summary

Ramsay Caroline Frances reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Caroline Frances Ramsay received an award of 32 Common Shares on 2026-07-06 as dividend equivalent shares tied to her outstanding equity awards. These compensation-related shares were granted at no cash cost, bringing her direct holdings to 10,709 Common Shares after the transaction.

Rhea-AI Summary

Boeren Leni reported acquisition or exercise transactions in this Form 4 filing.

AEGON LTD. director Leni Boeren received a grant of 4,160 Common Shares on June 10, 2026 as equity compensation. The shares were awarded at a price of $0.00 per share and are subject to time-based vesting under the applicable grant agreement. After this grant, Boeren directly holds 4,160 Common Shares.

Rhea-AI Summary

AEGON LTD. director Caroline Frances Ramsay reported a routine tax-related share disposition. On May 7, 2026, 2,552 Common Shares were withheld at $8.3583 per share to cover tax obligations associated with equity compensation. After this non-market tax-withholding event, she continues to hold 10,677 Common Shares directly.

Rhea-AI Summary

AEGON LTD. Chief Financial Officer Russell Duncan James reported a tax-related share transfer. He used 59,926 Common Shares on a Form 4/A as a tax-withholding disposition at $7.1512 per share to satisfy tax obligations, rather than an open-market sale. Following this transaction, he directly holds 462,972 Common Shares.

Rhea-AI Summary

AEGON LTD. Chief Financial Officer Russell Duncan James reported a Form 4 transaction where 61,678 Common Shares were disposed of at $7.1512 per share to satisfy tax obligations through share withholding. This was a non-open-market, tax-withholding disposition rather than a discretionary sale. Following the transaction, he directly holds 461,220 Common Shares.

Rhea-AI Summary

AEGON LTD. director Karen Fawcett reported a routine tax-related share disposition. On this Form 4, 2,632 Common Shares were delivered at $7.1512 per share to satisfy tax obligations, classified as a tax-withholding disposition. Following the transaction, she directly holds 8,755 Common Shares.

Rhea-AI Summary

AEGON LTD. director Thomas Peter Wellauer reported a routine tax-related share disposition. On March 25, 2026, 2,632 common shares were delivered at an implied price of $7.1512 per share to satisfy tax obligations. After this tax-withholding transaction, he directly holds 11,215 common shares.

Rhea-AI Summary

AEGON LTD. Chief Executive Officer Eilard Friese reported a disposition of 100,521 common shares on March 25, 2026 to satisfy tax obligations by delivering shares. This tax-withholding event was not an open-market trade. After the transaction, he directly held 612,817 common shares.

Rhea-AI Summary

AEGON LTD. officer Wilford H. Fuller reported a tax-related share disposition. On this Form 4, 221,990 Common Shares were transferred at a value of $7.1512 per share to satisfy tax obligations by delivering securities, rather than through an open-market sale. After this tax-withholding transaction, Fuller directly holds 2,088,444 Common Shares, indicating he retains a substantial equity position in the company.